Quadratus Lumborum Block for Total Hip Arthroplasty

Part of paid clinical trials in Santa Monica, California.

Sponsor
University of California, Los Angeles
Study ID
NCT05247255
Phase
EARLY_PHASE1
Status
Enrolling By Invitation

Conditions

  • Pain, Postoperative

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Active Comparator — DRUG
    QL block with 0.25% ropivacaine
  • Placebo Comparator — DRUG
    QL block with saline

Study Details

The quadratus lumborum (QL) block is a fascial plane block that has been described to provide analgesia from T7-L3 dermatomes. The investigators aim to evaluate the efficacy of QL blocks in patients undergoing primary total hip arthroplasty (THA).

Key Dates

Start date
Mar 29, 2022
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Intervention Group
    Quadratus lumborum nerve block with 0.25% ropivacaine
  • Placebo Comparator: Control Group
    Quadratus lumborum nerve block with saline

Primary Outcome Measure

Pain score [ Time Frame: Up to 48 hrs post op ]

Locations (1)

FacilityCityStateZIPSite coordinators
UCLA Medical Center, Santa MonicaSanta MonicaCalifornia90404-

Find similar trials in Santa Monica, CA

By research site
UCLA Medical Center, Santa Monica· Santa Monica, CA

Related Studies